An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn’s Disease

[1]  U. Syrbe,et al.  Bone marrow Th17 TNFα cells induce osteoclast differentiation and link bone destruction to IBD , 2014, Gut.

[2]  P. Ellul,et al.  Risk Factors for Osteoporosis in Crohn's Disease: Infliximab, Corticosteroids, Body Mass Index, and Age of Onset , 2013, Inflammatory bowel diseases.

[3]  W. Leslie,et al.  Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. , 2013, Clinical Gastroenterology and Hepatology.

[4]  N. Hayashi,et al.  Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. , 2011, Nutrition.

[5]  Z. Tulassay,et al.  Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients , 2009, Inflammatory bowel diseases.

[6]  M. Bronze,et al.  Osteoporosis in inflammatory bowel disease. , 2009, The American journal of medicine.

[7]  A. Licata,et al.  Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  E. Lewiecki,et al.  Bone density testing in clinical practice. , 2006, Arquivos brasileiros de endocrinologia e metabologia.

[9]  T. Zágoni,et al.  Infliximab Therapy Improves the Bone Metabolism in Fistulizing Crohn’s Disease , 2006, Digestive Diseases.

[10]  F. Shanahan,et al.  Altered levels of biochemical indices of bone turnover and bone‐related vitamins in patients with Crohn's disease and ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.

[11]  S. Targan,et al.  Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease , 2006, Journal of clinical gastroenterology.

[12]  G. Greenberg,et al.  Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease , 2005, The American Journal of Gastroenterology.

[13]  B. Ryan,et al.  Effect of antitumour necrosis factor‐α therapy on bone turnover in patients with active Crohn's disease: a prospective study , 2004, Alimentary pharmacology & therapeutics.

[14]  J. Belaiche,et al.  Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease , 2004, Alimentary pharmacology & therapeutics.

[15]  S. Travis,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.

[16]  E. Vasiliauskas,et al.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density , 2004, Gut.

[17]  L. Melton,et al.  Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  R. Eastell,et al.  Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  P. Meunier,et al.  Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? , 2001, The Lancet.

[20]  Susan R. Johnson,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.

[21]  R. Eastell,et al.  Biological Variability of Serum and Urinary N‐Telopeptides of Type I Collagen in Postmenopausal Women , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  G. Porro,et al.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis , 2000, Journal of internal medicine.

[23]  P. Delmas,et al.  Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  J. Mayberry,et al.  Osteoporosis and Determinants of Bone Density in Patients with Crohn's Disease , 1998, Digestive Diseases and Sciences.

[25]  R. Eliakim,et al.  Femoral neck osteopenia in patients with inflammatory bowel disease , 1998, American Journal of Gastroenterology.

[26]  Z. Tulassay,et al.  Altered Bone Metabolism in Inflammatory Bowel Disease , 1998, American Journal of Gastroenterology.

[27]  J. Jahnsen,et al.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. , 1997, Gut.

[28]  I. Forgacs,et al.  Reduced bone density in patients with inflammatory bowel disease. , 1997, Gut.

[29]  S. Majumdar,et al.  Noninvasive assessment of bone mineral and structure: State of the art , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  L. Melton,et al.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. , 1996, Bone.

[31]  W. Hannan,et al.  Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. , 1994, Gastroenterology.

[32]  M. Dougados,et al.  Low bone mineral density in patients with inflammatory bowel disease , 1992, Digestive Diseases and Sciences.

[33]  J. Bengoa,et al.  Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. , 1991, The American journal of clinical nutrition.

[34]  藤倉雄二,et al.  わが国における成人市中肺炎の原因微生物の変遷(Meta‐analysis and systematic review) , 2017 .

[35]  A. Sakuraba,et al.  Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  M. Crohn.  Osteoporosis in Patients with Inflammatory Bowel Disease , 2005 .

[37]  B. Drinkwater,et al.  Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. , 1997, The American journal of medicine.

[38]  M. D. de Broe,et al.  Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  S. Gerlach,et al.  Diagnosis and Therapy , 1981 .